4.3 Letter

Barriers and Facilitators to Buprenorphine Prescribing for Opioid Use Disorder in the Veterans Health Administration During COVID-19

期刊

JOURNAL OF ADDICTION MEDICINE
卷 15, 期 5, 页码 439-440

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ADM.0000000000000786

关键词

-

资金

  1. U.S. Department of Veterans Affairs Veterans Integrated Service Network (VISN) 19
  2. VA Salt Lake City Health Care System (VASLCHCS)
  3. Vulnerable Veteran Innovative PACT (VIP) Initiative at the VASLCHCS
  4. Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah
  5. VA Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) Partnered Evaluation Initiative
  6. VIP Initiative
  7. VISN 19/QUERI [PII 18-181, QUERI PII 19-321]
  8. VA [QUERI PEI 19-001]
  9. NIH NIDA [1UG1DA04944-01]

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据